• Health & Medicine

Lung cancer immunotherapy approved for NHS patients in England

An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer. An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer.

28 March 2019

• Science & Technology

The immune system preys on growing lung cancers, forcing them to evolve to survive

Scientists are taking a leaf out of Darwin's evolutionary handbook to understand how lung cancer evolves. Scientists are taking a leaf out of Darwin's evolutionary handbook to understand how lung cancer evolves.

20 March 2019

• Health & Medicine

Lung cancer treatment combo given initial NHS ‘no’ in England

A treatment combination has been provisionally rejected for people with certain types of lung cancer on the NHS in England. A treatment combination has been provisionally rejected for people with certain types of lung cancer on the NHS in England.

12 February 2019

• Health & Medicine
• Policy & Insight

Opinion: 'NHS targeted lung health checks are another reason to be positive about lung cancer'

The roll-out of mobile NHS scanners will save lives from lung cancer. But staff shortages, stop smoking services and treatment inequalities can't be ignored. The roll-out of mobile NHS scanners will save lives from lung cancer. But staff shortages, stop smoking services and treatment inequalities can't be ignored.

8 February 2019

• Health & Medicine

NHS to roll out mobile lung cancer scanning across England

Lung cancer scanning trucks will be rolled out to supermarket car parks across the country in a drive to detect the disease earlier. Lung cancer scanning trucks will be rolled out to supermarket car parks across the country in a drive to detect the disease earlier.

8 February 2019

• Health & Medicine

Half a million fewer deaths from lung cancer in 40 years

Lung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the rate had stayed the same Lung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the rate had stayed the same

1 February 2019

• Science & Technology
• Health & Medicine

Lung cancer screening part 2: research into detection technology could lead to better tests

Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening. Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.

6 December 2018

• Health & Medicine

Lung cancer screening part 1: the benefits and harms according to clinical trials

Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms. Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms.

4 December 2018

• Science & Technology

Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb join forces to map out lung cancer immunology

This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments. This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments.

30 November 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with lung cancer

Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England. Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England.

22 November 2018

• Health & Medicine

Mirati Therapeutics joins Cancer Research UK’s Stratified Medicine Programme

Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme. Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme.

20 November 2018